Reactivity of pulmonary circulation and right ventricle function to inhaled nitric oxide in systemic sclerosis patients

about

Novel Therapeutic Strategies for Reducing Right Heart Failure Associated Mortality in Fibrotic Lung Diseases.

P2860

Q43184339-7F8177D9-03D7-4802-99BC-437EA5249CF9

P2860

Reactivity of pulmonary circulation and right ventricle function to inhaled nitric oxide in systemic sclerosis patients

Item

http://www.wikidata.org/entity/Q35644221

description

2011 nî lūn-bûn

@nan

2011年の論文

@ja

2011年論文

@yue

2011年論文

@zh-hant

2011年論文

@zh-hk

2011年論文

@zh-mo

2011年論文

@zh-tw

2011年论文

@wuu

2011年论文

@zh

2011年论文

@zh-cn

name

Reactivity of pulmonary circul ...... in systemic sclerosis patients

@ast

Reactivity of pulmonary circul ...... in systemic sclerosis patients

@en

type

Item

label

Reactivity of pulmonary circul ...... in systemic sclerosis patients

@ast

Reactivity of pulmonary circul ...... in systemic sclerosis patients

@en

prefLabel

Reactivity of pulmonary circul ...... in systemic sclerosis patients

@ast

Reactivity of pulmonary circul ...... in systemic sclerosis patients

@en

P1476

Reactivity of pulmonary circul ...... in systemic sclerosis patients

@en

P2093

Ewa Czarnobilska

http://www.w3.org/2001/XMLSchema#string

Grzegorz Goncerz

http://www.w3.org/2001/XMLSchema#string

Jacek Musial

http://www.w3.org/2001/XMLSchema#string

Jan Sznajd

http://www.w3.org/2001/XMLSchema#string

Joanna Wilisowska

http://www.w3.org/2001/XMLSchema#string

Krzysztof Gryga

http://www.w3.org/2001/XMLSchema#string

P2860

Systemic sclerosis-associated pulmonary arterial hypertension

Outcome measures in pulmonary arterial hypertension associated with systemic sclerosis.

EULAR recommendations for the treatment of systemic sclerosis: a report from the EULAR Scleroderma Trials and Research group (EUSTAR).

Lung involvement in scleroderma.

Borderline pulmonary arterial pressure is associated with decreased exercise capacity in scleroderma.

Clinical value of vasodilator test with inhaled nitric oxide for predicting long-term response to oral vasodilators in pulmonary hypertension.

Significant improvement of right ventricular function by imatinib mesylate in scleroderma-associated pulmonary arterial hypertension.

Survival in pulmonary hypertension associated with the scleroderma spectrum of diseases: impact of interstitial lung disease.

Inhaled nitric oxide as a screening vasodilator agent in primary pulmonary hypertension. A dose-response study and comparison with prostacyclin.

P304

99-104

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1007/S10067-011-1792-4

http://www.w3.org/2001/XMLSchema#string

P433

http://www.w3.org/2001/XMLSchema#string

P478

http://www.w3.org/2001/XMLSchema#string

P50

Piotr Podolec

W Płazak

P577

2011-06-14T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P5875

51217033

http://www.w3.org/2001/XMLSchema#string

P698

21670950

http://www.w3.org/2001/XMLSchema#string

P932

3249214

http://www.w3.org/2001/XMLSchema#string

Reactivity of pulmonary circulation and right ventricle function to inhaled nitric oxide in systemic sclerosis patients

about

P2860

P2860

Reactivity of pulmonary circulation and right ventricle function to inhaled nitric oxide in systemic sclerosis patients

description

name

type

label

prefLabel

P1433

P1476

P2093

P2860

P304

P31

P356

P433

P478

P50

P577

P5875

P698

P932

P356

P1433

P1476

P2093

P2860

P304

P31

P356

P433

P478

P50

P577

P5875

P698

P932